CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 75-95% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Siemens Healthineers starts carve-out of diagnostics business

By Reuters News

Nov 5 - German medical technology company Siemens Healthineers SHLG.DE said on Thursday it had begun carving out its diagnostics business, which it plans to rebrand as Olyrian Diagnostics ahead of a future divestment.

The company said the separation process had started and was expected to be completed by mid-2028.

Siemens Healthineers had previously said the separation could take around two years and indicated the business might no longer form part of the group by 2030.

Olyrian Diagnostics will remain part of Siemens Healthineers during the transition period. The business produces more than 16 billion diagnostic tests annually. It also accounts for approximately 20% of Healthineers' workforce and generates 17% of its total revenue.

The company, which is renaming itself "Healthineers," said a separate name and brand would help position the unit as a standalone business during the transition.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.